We are live on
!
Find out more
IIC
Integrated Investment Consultants Portfolio holdings
AUM
$471M
1-Year Est. Return
20.31%
This Fund
S&P 500
This Quarter
Est. Return
+5.51%
1 Year Est. Return
+20.31%
3 Year Est. Return
+59.13%
5 Year Est. Return
+67%
10 Year Est. Return
–
AUM
$316M
AUM Growth
-$2.6M
(-0.82%)
Cap. Flow
-$16.5M
Cap. Flow
% of AUM
-5.24%
Top 10 Holdings %
Top 10 Hldgs %
40.11%
Holding
301
New
23
Increased
94
Reduced
87
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.09M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$856K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$740K |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$663K |
| 5 |
iShares Morningstar Mid-Cap Growth ETF
IMCG
|
+$500K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$11.3M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$4.42M |
| 3 |
AstraZeneca
AZN
|
+$615K |
| 4 |
Genmab
GMAB
|
+$519K |
| 5 |
ASML
ASML
|
+$474K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.6% |
| 2 | Consumer Discretionary | 6.51% |
| 3 | Financials | 5.85% |
| 4 | Industrials | 4.93% |
| 5 | Healthcare | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$322B
| $2.05M | 0.65% |
17,795
+136
| +0.8% | +$15.4K |
|
27
Berkshire Hathaway Class B
BRK.B
$1.11T
| $2.05M | 0.65% |
6,017
-199
| -3% | -$64.9K |
|
28
Amazon
AMZN
$2.94T
| $2.03M | 0.64% |
15,597
-102
| -0.6% | -$11.6K |
|
29
Meta Platforms (Facebook)
META
$1.53T
| $1.95M | 0.62% |
6,792
+55
| +0.8% | +$13.6K |
|
30
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.9B
| $1.84M | 0.58% |
22,460
-1,416
| -6% | -$112K |
|
31
Sun Communities
SUI
$14.6B
| $1.84M | 0.58% |
14,084
| – | – |
|
32
Vanguard High Dividend Yield ETF
VYM
$83.7B
| $1.76M | 0.56% |
16,596
| – | – |
|
33
iShares Core S&P Small-Cap ETF
IJR
$112B
| $1.48M | 0.47% |
14,895
-1,479
| -9% | -$141K |
|
34
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
| $1.4M | 0.44% |
6,362
+24
| +0.4% | +$5.01K |
|
35
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
| $1.28M | 0.4% |
6,197
+494
| +9% | +$95.7K |
|
36
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $1.25M | 0.4% |
31,591
-525
| -2% | -$20.6K |
|
37
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $1.22M | 0.39% |
29,890
-1,858
| -6% | -$74.9K |
|
|
38
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
| $1.19M | 0.38% |
15,787
+9,735
| +161% | +$740K |
|
39
AB InBev
BUD
$159B
| $1.18M | 0.37% |
20,767
-928
| -4% | -$56.1K |
|
40
Stryker
SYK
$133B
| $1.15M | 0.36% |
3,761
+40
| +1% | +$11.6K |
|
41
Chevron
CVX
$385B
| $1.01M | 0.32% |
6,418
+36
| +0.6% | +$5.77K |
|
42
iShares S&P 500 Growth ETF
IVW
$76.9B
| $991K | 0.31% |
14,064
+12
| +0.1% | +$793 |
|
43
iShares International Small Cap Equity Factor ETF
ISCF
$678M
| $990K | 0.31% |
32,106
| – | – |
|
44
Fidelity MSCI Real Estate Index ETF
FREL
$1.46B
| $983K | 0.31% |
39,167
| – | – |
|
45
AbbVie
ABBV
$442B
| $980K | 0.31% |
7,277
-749
| -9% | -$110K |
|
46
Abbott
ABT
$190B
| $964K | 0.31% |
8,838
+45
| +0.5% | +$4.8K |
|
47
Eli Lilly
LLY
$1.09T
| $960K | 0.3% |
2,047
-275
| -12% | -$115K |
|
48
PepsiCo
PEP
$188B
| $953K | 0.3% |
5,143
+281
| +6% | +$52.4K |
|
49
UWM Holdings
UWMC
$2.36B
| $911K | 0.29% |
162,767
-27,977
| -15% | -$151K |
|
50
iShares S&P 500 Value ETF
IVE
$49.9B
| $909K | 0.29% |
5,642
+373
| +7% | +$57.4K |
|
Similar funds
RCM
SIA
BSI
IC
GBWM
CTWM
CCM
SP
Integrated Investment Consultants's Q2 2023 Portfolio in Review
As of Q2 2023, Integrated Investment Consultants held 301 positions worth $316M, down 0.82% from $318M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Integrated Investment Consultants withdrew a net $16.5M in Q2 2023, closing 28 positions and reducing 87 holdings. Its most notable exit was AstraZeneca, an estimated $615K position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Integrated Investment Consultants opened a new position in Invesco S&P 500 GARP ETF worth $489K.
- Integrated Investment Consultants's largest Q2 2023 buy was Invesco S&P 500 GARP ETF: 5,386 shares worth $489K.
- Integrated Investment Consultants added most to iShares Core MSCI EAFE ETF in Q2 2023, an estimated $1.09M increase.
- Integrated Investment Consultants's biggest Q2 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $11.3M.
- Integrated Investment Consultants fully exited AstraZeneca in Q2 2023, selling an estimated $615K.
- Integrated Investment Consultants's ten largest holdings make up 40% of its $316M portfolio in Q2 2023.
- Integrated Investment Consultants opened 23 new positions and closed 28 in Q2 2023.
- Integrated Investment Consultants's portfolio value fell 0.82% quarter-over-quarter to $316M.
Based on Integrated Investment Consultants's 13F filing for Q2 2023, filed 18 Jul 2023.